FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3087302326> ?p ?o ?g. }

• W3087302326 endingPage "668" @default.
• W3087302326 startingPage "649" @default.
• W3087302326 abstract "Tumour necrosis factor (TNF)-α inhibitors have been widely used for the treatment of moderate-to-severe inflammatory bowel disease (IBD). TNFα also plays an important role in the regulation of weight homeostasis and metabolism and has been linked to variations in anthropometric responses. This relationship in patients with IBD has yet to be determined. Our objective was to evaluate the effects of TNFα inhibitors on changes in anthropometric measures in both adults and children with IBD through a systematic review and meta-analysis. Multiple database searches identified studies involving children and adults with IBD and treated with TNFα inhibitors and reporting at least one primary outcome measure. Where possible, data were combined for meta-analysis. The primary outcomes included weight, body mass index (BMI), waist circumference, height, height/velocity, and fat and lean mass. Secondary outcomes included surrogate markers of disease activity. A random-effects model was used to estimate the standardised mean difference (SMD). In total, 23 cohort studies (total 1167 participants) met the inclusion criteria. Meta-analysis was performed on 13 of these studies. In children, 6–29.3 months of anti-TNFα therapy had a small but statistically significant effect on weight (SMD 0.31; 95% confidence interval [CI] 0.12–0.49; P = 0.001) with a mean gain in z score of 0.30 (standard error [SE] 0.12). In adults, 2–22.4 months of treatment had a moderate effect on BMI (SMD 0.72; 95% CI 0.17–1.26; P = 0.010; mean gain 1.23 kg/m2; SE 0.21). A small but statistically significant increase in BMI z score was found in children (SMD 0.28; 95% CI 0.03–0.53; P = 0.026; mean change 0.31 ± standard deviation [SD] 0.14) after 12–29.3 months of therapy. A meta-analysis of four studies found a negligible but statistically significant increase in height (SMD 0.16; 95% CI 0.06–0.26; P = 0.002; mean change 0.17 z score [SE 0.05]). A negligible effect on fat mass (SMD 0.24; 95% CI −0.19–0.66; P = 0.272) was found in a meta-analysis of five studies. Of note, despite the high heterogeneity among the studies that addressed the issue, these results were also consistently supported by findings from studies not included in the meta-analysis and reviewed in the systematic review. Unfortunately, a lack of data meant we were unable to perform moderator analysis on observed heterogeneity. Anti-TNFα treatment appears to be associated with an increase in body weight, BMI, and other anthropometric parameters. Given the differing courses of IBD between children and adults, this association should be considered before initiating biologics for undernourished, overweight, and obese patients. Registration: PROSPERO registration number CRD42020163079." @default.
• W3087302326 created "2020-09-25" @default.
• W3087302326 creator A5005557373 @default.
• W3087302326 creator A5010848776 @default.
• W3087302326 creator A5013047374 @default.
• W3087302326 creator A5025509647 @default.
• W3087302326 creator A5028167820 @default.
• W3087302326 creator A5029915839 @default.
• W3087302326 creator A5053862721 @default.
• W3087302326 creator A5060942252 @default.
• W3087302326 creator A5067115095 @default.
• W3087302326 creator A5068943546 @default.
• W3087302326 creator A5085998598 @default.
• W3087302326 date "2020-09-17" @default.
• W3087302326 modified "2023-10-18" @default.
• W3087302326 title "Changes in Anthropometric Parameters After Anti-TNFα Therapy in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis" @default.
• W3087302326 cites W1524805008 @default.
• W3087302326 cites W1536852940 @default.
• W3087302326 cites W1587903471 @default.
• W3087302326 cites W1662047237 @default.
• W3087302326 cites W1889163905 @default.
• W3087302326 cites W1970527591 @default.
• W3087302326 cites W1972826557 @default.
• W3087302326 cites W1975525497 @default.
• W3087302326 cites W1983411407 @default.
• W3087302326 cites W1984990383 @default.
• W3087302326 cites W1990440671 @default.
• W3087302326 cites W2003624191 @default.
• W3087302326 cites W2005501262 @default.
• W3087302326 cites W2017145948 @default.
• W3087302326 cites W2018757636 @default.
• W3087302326 cites W2021387012 @default.
• W3087302326 cites W2027602343 @default.
• W3087302326 cites W2034524595 @default.
• W3087302326 cites W2044677679 @default.
• W3087302326 cites W2052849191 @default.
• W3087302326 cites W2055837685 @default.
• W3087302326 cites W2061297831 @default.
• W3087302326 cites W2065373112 @default.
• W3087302326 cites W2080856124 @default.
• W3087302326 cites W2083047982 @default.
• W3087302326 cites W2087058051 @default.
• W3087302326 cites W2091289145 @default.
• W3087302326 cites W2098987367 @default.
• W3087302326 cites W2111687706 @default.
• W3087302326 cites W2113155951 @default.
• W3087302326 cites W2123926474 @default.
• W3087302326 cites W2129515463 @default.
• W3087302326 cites W2138012664 @default.
• W3087302326 cites W2151289937 @default.
• W3087302326 cites W2153881101 @default.
• W3087302326 cites W2166295622 @default.
• W3087302326 cites W2259099015 @default.
• W3087302326 cites W2270754374 @default.
• W3087302326 cites W2313391595 @default.
• W3087302326 cites W2319402992 @default.
• W3087302326 cites W2327912554 @default.
• W3087302326 cites W2335770115 @default.
• W3087302326 cites W2416839071 @default.
• W3087302326 cites W2512170617 @default.
• W3087302326 cites W2513132225 @default.
• W3087302326 cites W2519824125 @default.
• W3087302326 cites W2559678284 @default.
• W3087302326 cites W2566424873 @default.
• W3087302326 cites W2605479269 @default.
• W3087302326 cites W2735900537 @default.
• W3087302326 cites W2754463986 @default.
• W3087302326 cites W2783242767 @default.
• W3087302326 cites W2912610515 @default.
• W3087302326 cites W2951849975 @default.
• W3087302326 cites W3001350765 @default.
• W3087302326 cites W4243177274 @default.
• W3087302326 doi "https://doi.org/10.1007/s40259-020-00444-9" @default.
• W3087302326 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7519901" @default.
• W3087302326 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32940873" @default.
• W3087302326 hasPublicationYear "2020" @default.
• W3087302326 type Work @default.
• W3087302326 sameAs 3087302326 @default.
• W3087302326 citedByCount "5" @default.
• W3087302326 countsByYear W30873023262021 @default.
• W3087302326 countsByYear W30873023262022 @default.
• W3087302326 crossrefType "journal-article" @default.
• W3087302326 hasAuthorship W3087302326A5005557373 @default.
• W3087302326 hasAuthorship W3087302326A5010848776 @default.
• W3087302326 hasAuthorship W3087302326A5013047374 @default.
• W3087302326 hasAuthorship W3087302326A5025509647 @default.
• W3087302326 hasAuthorship W3087302326A5028167820 @default.
• W3087302326 hasAuthorship W3087302326A5029915839 @default.
• W3087302326 hasAuthorship W3087302326A5053862721 @default.
• W3087302326 hasAuthorship W3087302326A5060942252 @default.
• W3087302326 hasAuthorship W3087302326A5067115095 @default.
• W3087302326 hasAuthorship W3087302326A5068943546 @default.
• W3087302326 hasAuthorship W3087302326A5085998598 @default.
• W3087302326 hasBestOaLocation W30873023261 @default.
• W3087302326 hasConcept C126322002 @default.
• W3087302326 hasConcept C2776193436 @default.
• W3087302326 hasConcept C2778260677 @default.
• W3087302326 hasConcept C2779134260 @default.

• next